Rheumatoid lung disease occurring in a patient with seropositive rheumatoid arthritis (RF-positive), where the specific joint site is not documented or identified.
Verified May 8, 2026 · 6 sources ↓
- Status
- Billable
- Chapter
- 13
- Related CPT
- 10
- Region
- Other
Documentation tips
What should appear in the chart to support M05.10.
Source · Editorial brief grounded in 6 cited references ↓
- Record confirmed RF positivity explicitly — document the lab value or state 'seropositive' in the assessment to justify any M05.x code over M06.x.
- Name the pulmonary manifestation specifically (e.g., interstitial lung disease, pleuritis, pulmonary nodules, bronchiectasis) so the rheumatoid lung disease linkage is clear and auditable.
- Document which joints are involved, even if the primary concern is pulmonary — this allows upgrade from M05.10 (unspecified site) to a site-specific M05.1x code.
- Note current DMARD or biologic therapy in the treatment plan; this supports medical necessity for ongoing imaging, pulmonary function testing, and specialist co-management.
- If imaging (HRCT, chest X-ray) was performed or interpreted, document the findings explicitly and tie them to the RA diagnosis — non-clinicians cannot infer the connection from radiology reports alone.
Related CPT procedures
Procedure codes commonly billed with M05.10. Linking the right diagnosis to the right procedure is what establishes medical necessity.
Source · CMS LCDs · AAOS specialty guidance · claims-pattern analysis
Common coding pitfalls
The recurring mistakes coders make with M05.10 and adjacent codes.
Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓
- Using M05.10 when RF status is not confirmed — if seropositivity isn't documented, the correct category is M06, not M05.
- Defaulting to M05.10 when the joint site is actually documented; always assign the site-specific 6th character (M05.11–M05.19) when laterality or joint is named.
- Confusing rheumatoid lung disease (M05.1x) with respiratory infections or other pulmonary conditions that may coexist — each requires its own code and clear clinical linkage in the documentation.
- Omitting the underlying RA code when billing pulmonary procedures — M05.10 should be sequenced as the principal or primary diagnosis with any additional pulmonary function or imaging codes linked appropriately.
- Coding M05.10 based solely on a prior-encounter diagnosis without verifying that the condition was actively addressed or monitored at the current encounter.
Clinical context
Source · Editorial summary grounded in 6 cited references ↓
M05.10 applies when a clinician documents rheumatoid lung disease as a manifestation of seropositive RA (rheumatoid factor-positive) but does not specify which joint or anatomical site is affected. Rheumatoid lung disease encompasses pulmonary manifestations of RA including interstitial lung disease, pleuritis, pulmonary nodules, and bronchiectasis. The M05.1x subcategory requires a 6th character: 0 = unspecified site, 1 = shoulder, 2 = elbow, 3 = wrist, 4 = hand, 5 = hip, 6 = knee, 7 = ankle and foot, 9 = multiple sites. Use M05.10 only when the provider has not documented which joint is involved.
M05.10 is a seropositive RA code — RF positivity must be established by lab results or clearly stated in the documentation. If RF is negative or not tested, the correct parent category is M06 (rheumatoid arthritis without rheumatoid factor). If RA is confirmed RF-positive but no lung involvement is documented, do not use M05.10; drop to M05.9x or a more specific M05 subcategory reflecting the actual manifestation.
This code carries HCC risk-adjustment weight in CMS models. Unspecified-site coding (the '0' 6th character) may trigger payer scrutiny and downcoding during risk adjustment audits. Whenever a joint site is documented, always assign the site-specific code over M05.10.
Sibling codes
Other billable codes under M05.1 (laterality / anatomic variants).
Frequently asked questions
Source · Generated from the editorial pipeline, verified against 6 cited references ↓
01What distinguishes M05.10 from M06.x codes?
02When should I use M05.10 versus a more specific M05.1x code?
03Does M05.10 require a separate pulmonary diagnosis code?
04Is M05.10 valid for HCC risk adjustment?
05Can M05.10 be used if the patient's RA is currently in remission?
06What imaging documentation supports M05.10?
07Does M05.10 apply when RF is borderline elevated but not definitively positive?
Sources & references
Editorial content was developed using the following public sources. Last verified May 8, 2026.
- 01CDC ICD-10-CM Tabular List 2026
- 02aapc.comhttps://www.aapc.com/codes/icd-10-codes/M05.10
- 03icd10data.comhttps://www.icd10data.com/ICD10CM/Codes/M00-M99/M05-M14/M05-/M05.1
- 04providers.highmark.comhttps://providers.highmark.com/content/dam/highmark/en/providerresourcecenter/pdfs/all/documents/pdfs/resources-and-education/clinical-quality-education/coding/rheumatoid-arthritis-coding-documentation.pdf
- 05pmc.ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC7560310/
- 06rhinomds.comhttps://rhinomds.com/m05-icd-10-codes-for-rheumatoid-arthritis-2026-a-billing-coding-guide/
Mira AI Scribe
Mira AI Scribe captures RF lab positivity, the specific pulmonary manifestation (ILD, pleuritis, nodules), any HRCT or chest imaging findings, current DMARD/biologic regimen, and the joint sites involved — preventing a drop to unspecified-site M05.10 when a more specific M05.1x code is supportable, and flagging missing RF documentation before the claim goes out.
See how Mira captures M05.10 documentation